NCT05506059 (BES2T) is a NA clinical trial of Ultrasound in Stroke Volume, sponsored by The Guthrie Clinic.

Who is sponsoring NCT05506059?

NCT05506059 is sponsored by The Guthrie Clinic.

What drugs are being tested in NCT05506059?

Interventions in NCT05506059: Ultrasound.

What condition does NCT05506059 study?

NCT05506059 studies Stroke Volume, Cardiovascular Diseases.

Is NCT05506059 still recruiting?

NCT05506059 is currently completed. Last updated 13 February 2024.

Last reviewed 2024-02-13 · How we verify

NCT05506059: BES2T

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Heart Ultrasound by Emergency Medicine Residents as an Estimate of Heart Function

Completed NA Last updated 13 February 2024

What this trial tests

NA trial testing Ultrasound in Stroke Volume in 17 participants. Completed in 11 August 2023.

Timeline

10 September 2022

Primary endpoint
11 August 2023

11 August 2023

Quick facts

Lead sponsor	The Guthrie Clinic
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	non randomized
Design	parallel
Masking	single
Primary purpose	other
Enrollment	17
Start date	10 September 2022
Primary completion	11 August 2023
Estimated completion	11 August 2023
Sites	1 location across United States

Drugs / interventions tested

Ultrasound

Conditions studied

Stroke Volume — all drugs for Stroke Volume →
Cardiovascular Diseases — all drugs for Cardiovascular Diseases →

Sponsor

The Guthrie Clinic

Who can join

18 and older, any sex, with Stroke Volume or Cardiovascular Diseases. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this research is to better understand the use of heart ultrasounds to estimate heart function.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Ultrasound

Trials testing the same drug.

NCT07467382 — GOAT (Gait Observation of Achilles Tendon) · not yet recruiting
NCT07505433 — Ultrasound Monitoring of Bone Healing in Ilizarov Bone Transport · not yet recruiting
NCT07498517 — Safety and Efficacy of a Single Dose of Gruticibart to Prevent CRT · Phase 2 · not yet recruiting
NCT07342790 — Artificial Intelligence Clinical Decision · NA · not yet recruiting
NCT07169890 — Clinical Insights Into Dextrose Phonophoresis on Mild to Moderate Acne Vulgaris · NA · completed

Other The Guthrie Clinic trials

Trials by the same sponsor.

NCT05980533 — Portable Ultrasound to Predict Heart Failure Readmission Risk · NA · withdrawn
NCT05436236 — Effect of Cannabis (Marijuana) on Stomach Emptying Before Surgery · withdrawn
NCT07018232 — Enhancing Timely Access to Medication Changes: The Role of Pharmacists in Overcoming Transitions of Care Challenges · completed
NCT06518369 — Preoperative Prehabilitation Program For Geriatric Patients in a Rural Healthcare Setting · completed
NCT05694338 — Frailty in Patients With Gastrointestinal Cancer Who Are Undergoing Major Surgery · active not recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05506059 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by The Guthrie Clinic
Last refreshed: 13 February 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05506059.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing